Berlin, July 23, 2015. The Supervisory Board of MOLOGEN AG (ISIN DE0006637200/WKN 663720) today appointed Dr. Mariola Söhngen, co-founder of PAION AG (and Management Board member up to October 31, 2015, as Chief Medical Officer; CMO), as Member of the Executive Board and new Chief Executive Officer (CEO) of MOLOGEN AG with effect from November 1, 2015. She will be in charge of Research, Business Development, Strategy and Partnering.
The presiding CEO of MOLOGEN AG, Dr. Matthias Schroff, has announced that he will resign from his post as chairman of the Executive Board on October 31, 2015 and be leaving the Executive Board with effect from December 31, 2015, by mutual agreement with the Supervisory Board. In the interim period from November 1, 2015 to December 31, 2015, Dr. Schroff will work as Executive Board member in cooperation with Dr. Söhngen to ensure a smooth transition of the chairmanship.
In addition, Jörg Petraß (Chief Financial Officer; CFO) has also informed the Supervisory Board that he does not plan to extend his tenure as Executive Board Member of MOLOGEN AG, which is due to run out on December 31, 2015. However, he has offered to act as a consultant for a transitional period to enable orderly succession planning and the induction of his successor.
Contact
Claudia Nickolaus
Head of Investor Relations & Corporate Communications
Tel: +49 - 30 - 84 17 88 – 38
Fax: +49 - 30 - 84 17 88 - 50
investor@mologen.com
Help employers find you! Check out all the jobs and post your resume.
